Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL)

NCT00795613 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

450

Enrollment

OTHER

Sponsor class

Conditions

HODGKIN LYMPHOMA

Interventions

DRUG: ESCALATED BEACOPP
DRUG: CONVENTIONAL ABVD

Sponsor

Ospedale Santa Croce-Carle Cuneo

Collaborators

[object Object]
[object Object]